نتایج جستجو برای: crossmatch

تعداد نتایج: 426  

Journal: :American journal of clinical pathology 2005
K F Wong Angela M Y Kwan

The operating theater blood transaction system (OTBTS) is a virtual blood banking system that allows computer crossmatch-compatible blood ordering and delivery in the operating theater remote from the hospital blood bank. It was developed and implemented in our hospital in 1997 and was expanded in 2002 to include an unmatched blood module that allows ordering and issuing unmatched RBCs for intr...

Journal: :Transplant immunology 2011
Eapen K Jacob Steve R De Goey Manish J Gandhi

Pre-transplant (Tx) presence of HLA antibodies (HLA-Ab) especially donor specific antibodies (DSA) has been correlated with post-Tx rejection. While crossmatch (XM) is the specific method to identify DSA, logistical reasons prevent performing a prospective XM in all transplants. In such cases DSA as identified by solid-phase assay (SPA) are being used to perform a virtual crossmatch (VXM). We p...

2016
Judith Desoutter Marie-Joëlle Apithy Ségolène Bartczak Nicolas Guillaume

Crossmatching is essential prior to kidney transplantation to confirm compatibility between the donor and the recipient, particularly to prevent acute antibody-mediated rejection. An unexpected positive crossmatch may be obtained in recipients with an autoimmune disease or preexisting antibodies not detected by single-antigen bead array due to complement interference or who have been previously...

Journal: :Indian Journal of Nephrology 2018

Journal: :Clinical transplantation 1989
Thomas E Starzl Anthony J Demetris Satoru Todo Yoogoo Kang Andreas Tzakis Rene Duquesnoy Leonard Makowka Barbara Banner Waldo Concepcion Kendrick A Porter

Sequential liver and kidney transplantation from the same donor was performed in 2 patients. The kidney in Patient 1, which was transplanted after the liver, was hyperacutely rejected and removed 6 hours later. The first liver as well as another liver transplanted 3 days later developed widespread hemorrhagic necrosis. Although the cytotoxic crossmatch of preoperative recipient serum with both ...

Journal: :Current opinion in immunology 2005
Ilias I N Doxiadis Rene J Duquesnoy Frans H J Claas

Highly sensitized patients (anti-HLA) on the kidney waiting list wait longer for a suitable crossmatch negative organ. At the moment there are two strategies to enhance transplantation of these patients. One approach is the determination of acceptable HLA mismatches and application of this knowledge for the selection of crossmatch negative donors, and the second is the desensitization of patien...

Journal: :Ophthalmology 1983
G N Foulks F P Sanfilippo J A Locascio J M MacQueen D V Dawson

Forty-eight consecutive patients at high risk for corneal graft rejection were transplanted with corneas from donors selected on the basis of a negative lymphocyte crossmatch, ABO blood group compatibility, and maximized HLA-A, -B matching. Graft survival in this study group was compared to a retrospective control group of 72 consecutive high-risk transplants performed in patients receiving ran...

Journal: :Transplant international : official journal of the European Society for Organ Transplantation 2012
Kyu Ha Huh Myoung Soo Kim Hae Jin Kim Dong Jin Joo Beom Seok Kim Man Ki Ju Soon Il Kim Yu Seun Kim

Recently, Luminex-crossmatch (LumXm) was introduced. The aim of this study was to evaluate clinical outcomes in sensitized recipients with a positive Luminex-crossmatch (LumXm (+)) and a negative complement-dependent cytotoxicity crossmatch (CDCXm (-)) after renal transplantation. Fifty-five renal transplant recipients with a CDCXm (-) and PRA class I or II ≥20% were enrolled in this study betw...

Journal: :American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2014
B J Orandi J M Garonzik-Wang A B Massie A A Zachary J R Montgomery K J Van Arendonk M D Stegall S C Jordan J Oberholzer T B Dunn L E Ratner S Kapur R P Pelletier J P Roberts M L Melcher P Singh D L Sudan M P Posner J M El-Amm R Shapiro M Cooper G S Lipkowitz M A Rees C L Marsh B R Sankari D A Gerber P W Nelson J Wellen A Bozorgzadeh A O Gaber R A Montgomery D L Segev

Incompatible live donor kidney transplantation (ILDKT) offers a survival advantage over dialysis to patients with anti-HLA donor-specific antibody (DSA). Program-specific reports (PSRs) fail to account for ILDKT, placing this practice at regulatory risk. We collected DSA data, categorized as positive Luminex, negative flow crossmatch (PLNF) (n = 185), positive flow, negative cytotoxic crossmatc...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید